Monarch Partners Asset Management LLC bought a new position in shares of Invacare Corporation (NYSE:IVC) during the second quarter, Holdings Channel reports. The institutional investor bought 19,110 shares of the health services provider’s stock, valued at approximately $252,000.

Several other institutional investors have also made changes to their positions in IVC. Pacific Ridge Capital Partners LLC boosted its stake in shares of Invacare Corporation by 29.8% in the first quarter. Pacific Ridge Capital Partners LLC now owns 41,450 shares of the health services provider’s stock valued at $493,000 after buying an additional 9,510 shares during the last quarter. AlphaOne Investment Services LLC boosted its stake in shares of Invacare Corporation by 3.3% in the first quarter. AlphaOne Investment Services LLC now owns 349,848 shares of the health services provider’s stock valued at $4,163,000 after buying an additional 11,069 shares during the last quarter. Alambic Investment Management L.P. boosted its stake in shares of Invacare Corporation by 20.3% in the first quarter. Alambic Investment Management L.P. now owns 146,231 shares of the health services provider’s stock valued at $1,740,000 after buying an additional 24,700 shares during the last quarter. State of Tennessee Treasury Department boosted its stake in shares of Invacare Corporation by 17.8% in the first quarter. State of Tennessee Treasury Department now owns 27,500 shares of the health services provider’s stock valued at $327,000 after buying an additional 4,150 shares during the last quarter. Finally, Parametric Portfolio Associates LLC boosted its stake in shares of Invacare Corporation by 15.1% in the first quarter. Parametric Portfolio Associates LLC now owns 167,334 shares of the health services provider’s stock valued at $1,991,000 after buying an additional 21,913 shares during the last quarter.

Shares of Invacare Corporation (IVC) opened at 13.60 on Tuesday. The stock has a 50 day moving average price of $13.88 and a 200-day moving average price of $12.90. Invacare Corporation has a 1-year low of $8.00 and a 1-year high of $16.65. The stock’s market capitalization is $447.03 million.

Invacare Corporation (NYSE:IVC) last released its quarterly earnings results on Monday, August 7th. The health services provider reported ($0.63) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.42) by $0.21. The company had revenue of $233.50 million during the quarter, compared to the consensus estimate of $243.03 million. Invacare Corporation had a negative return on equity of 12.79% and a negative net margin of 6.42%. The company’s revenue was down 15.1% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.33) earnings per share. On average, analysts forecast that Invacare Corporation will post ($1.65) earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This story was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://www.thecerbatgem.com/2017/08/15/19110-shares-in-invacare-corporation-ivc-acquired-by-monarch-partners-asset-management-llc.html.

Several brokerages recently weighed in on IVC. ValuEngine raised Invacare Corporation from a “sell” rating to a “hold” rating in a research note on Friday, August 4th. BidaskClub cut Invacare Corporation from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 2nd. Zacks Investment Research cut Invacare Corporation from a “hold” rating to a “sell” rating in a research note on Friday, June 16th. Sidoti reissued a “neutral” rating and issued a $12.00 target price (down from $14.00) on shares of Invacare Corporation in a research note on Monday, June 12th. Finally, Stephens raised Invacare Corporation from an “equal weight” rating to an “overweight” rating in a research note on Friday, April 28th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $14.50.

About Invacare Corporation

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Corporation (NYSE:IVC).

Institutional Ownership by Quarter for Invacare Corporation (NYSE:IVC)

Receive News & Stock Ratings for Invacare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare Corporation and related stocks with our FREE daily email newsletter.